{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:25:35Z","timestamp":1791588335803,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100022810","name":"State Key Laboratory for Advanced Metals and Materials","doi-asserted-by":"publisher","award":["2024MS06"],"award-info":[{"award-number":["2024MS06"]}],"id":[{"id":"10.13039\/100022810","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This article aims to elucidate the potential role of a comprehensive tooth extraction procedure in preventing mdication-related osteonecrosis of the jaw (MRONJ) through a prospective cohort study. By systematically assessing clinical outcomes following this procedure, the study seeks to provide evidence regarding its effectiveness in MRONJ prevention, thereby contributing to improved clinical guidelines and patient care related to dental extractions in at-risk populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients using anti-resorptive agents (ARAs) who required extraction of at least one tooth were included in the study. Patients\u2019 medical history, medication history, and intraoral dental conditions were documented, and CBCT scans were performed. Following a standardized treatment protocol, patients received professional oral cleaning and antibiotics preoperatively. During surgery, minimally invasive extraction and concentrated growth factor (CGF) filling were performed with meticulous suturing whenever possible. Postoperatively, mouthwash was used within one month. Follow-up visits were scheduled at 10, 30, and 90 days to monitor and analyze MRONJ incidence and surgical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 101 patients were included in the study, with 20 receiving oral ARAs for osteoporosis, 57 receiving intravenous ARAs for osteoporosis, 13 undergoing combination therapy for osteoporosis, and 11 using ARAs for malignancy. Zoledronic acid and denosumab were the most commonly used drugs. Increased bone density was observed on preoperative CBCT in 26 patients, and on postoperative CBCT at 90 days in 31 patients. In total, 248 teeth were extracted, mostly due to severe defects; periapical periodontitis and periodontitis were also major reasons for extraction. Most patients could not achieve complete and tight suturing. All patients remained free of MRONJ during the 90\u2011day postoperative period, with complete mucosal healing in every case.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This prospective cohort study provides evidence that implementing an effective and rational treatment protocol during tooth extractions significantly benefits high-risk MRONJ patients. Adherence to such protocols minimizes the risk of postoperative infection, fosters improved healing of extraction sites, and maximizes the prevention of MRONJ.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-04138-9","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T14:33:22Z","timestamp":1765290802000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Potential role of the comprehensive tooth extraction procedure in preventing medication related osteonecrosis of the jaw (MRONJ): a prospective cohort study"],"prefix":"10.1186","volume":"20","author":[{"given":"Yi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengke","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueni","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiange","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlin","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7804-5730","authenticated-orcid":false,"given":"Yang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"issue":"4","key":"4138_CR1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.oooo.2018.11.012","volume":"127","author":"R King","year":"2019","unstructured":"King R, Tanna N, Patel V. Medication-related osteonecrosis of the jaw unrelated to bisphosphonates and denosumab-a review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019;127(4):289\u201399.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"4138_CR2","doi-asserted-by":"crossref","unstructured":"Russell RGG. Bisphosphonates: the first 40 years. Bone. 2011;49(1).","DOI":"10.1016\/j.bone.2011.04.022"},{"issue":"2","key":"4138_CR3","doi-asserted-by":"publisher","first-page":"101645","DOI":"10.1016\/j.jormas.2023.101645","volume":"125","author":"IR Suryani","year":"2024","unstructured":"Suryani IR, Shujaat S, Ivkovi\u0107 U, Coucke W, Coropciuc R, Jacobs R. Risk of healing impairment following tooth extraction in patients administered with antiresorptive and non-antiresorptive polypharmacy. J Stomatol Oral Maxillofac Surg. 2024;125(2):101645.","journal-title":"J Stomatol Oral Maxillofac Surg"},{"issue":"6","key":"4138_CR4","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.jormas.2022.03.020","volume":"123","author":"A Cuozzo","year":"2022","unstructured":"Cuozzo A, Iorio-Siciliano V, Vaia E, Mauriello L, Blasi A, Ramaglia L. Incidence and risk factors associated to Medication-Related osteo necrosis of the jaw (MRONJ) in patients with osteoporosis after tooth extractions. A 12-months observational cohort study. J Stomatol Oral Maxillofac Surg. 2022;123(6):616\u201321.","journal-title":"J Stomatol Oral Maxillofac Surg"},{"issue":"3","key":"4138_CR5","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1016\/j.jds.2023.10.007","volume":"19","author":"K Suyama","year":"2024","unstructured":"Suyama K, Otsuru M, Nakamura N, Morishita K, Miyoshi T, Omori K, et al. Bone resection methods in medication-related osteonecrosis of the jaw in the mandible: an investigation of 206 patients undergoing surgical treatment. J Dent Sci. 2024;19(3):1758\u201369.","journal-title":"J Dent Sci"},{"issue":"1","key":"4138_CR6","doi-asserted-by":"publisher","first-page":"12890","DOI":"10.1038\/s41598-023-39755-6","volume":"13","author":"Y Sakamoto","year":"2023","unstructured":"Sakamoto Y, Sawada S, Kojima Y. Medication-related osteonecrosis of the jaw without osteolysis on computed tomography: a retrospective and observational study. Sci Rep. 2023;13(1):12890.","journal-title":"Sci Rep"},{"key":"4138_CR7","doi-asserted-by":"crossref","unstructured":"Dipalma G, Inchingolo AM, Malcangi G, Ferrara I, Viapiano F, Netti A et al. Sixty-Month follow up of clinical MRONJ cases treated with CGF and piezosurgery. Bioeng (Basel). 2023;10(7).","DOI":"10.3390\/bioengineering10070863"},{"issue":"3","key":"4138_CR8","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1177\/0022034511432170","volume":"91","author":"E Shimizu","year":"2012","unstructured":"Shimizu E, Tamasi J, Partridge NC. Alendronate affects osteoblast functions by crosstalk through EphrinB1-EphB. J Dent Res. 2012;91(3):268\u201374.","journal-title":"J Dent Res"},{"issue":"10","key":"4138_CR9","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1002\/jbmr.5650111017","volume":"11","author":"P David","year":"1996","unstructured":"David P, Nguyen H, Barbier A, Baron R. The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase. J Bone Min Res. 1996;11(10):1498\u2013507.","journal-title":"J Bone Min Res"},{"key":"4138_CR10","doi-asserted-by":"publisher","first-page":"116722","DOI":"10.1016\/j.bone.2023.116722","volume":"170","author":"R Coropciuc","year":"2023","unstructured":"Coropciuc R, Coopman R, Garip M, Gielen E, Politis C, Van den Wyngaert T, et al. Risk of medication-related osteonecrosis of the jaw after dental extractions in patients receiving antiresorptive agents - A retrospective study of 240 patients. Bone. 2023;170:116722.","journal-title":"Bone"},{"issue":"12","key":"4138_CR11","first-page":"774","volume":"32","author":"C Moon","year":"2024","unstructured":"Moon C, Kim H, Park JH, Park W, Kim HJ, Jung Y-S, et al. High-dose denosumab (Xgeva\u00ae) associated Medication-Related osteonecrosis of the jaws (MRONJ): incidence and clinical characteristics in a retrospective analysis of 1278 patients. Support Care Cancer. 2024;32(12):774.","journal-title":"Support Care Cancer"},{"key":"4138_CR12","doi-asserted-by":"crossref","unstructured":"D\u2019Agostino S, Valentini G, Dolci M, Ferrara E. Potential relationship between poor oral hygiene and MRONJ: an observational retrospective study. Int J Environ Res Public Health. 2023;20(7).","DOI":"10.3390\/ijerph20075402"},{"issue":"1","key":"4138_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40902-023-00398-2","volume":"45","author":"Y-D Kwon","year":"2023","unstructured":"Kwon Y-D, Jo H, Kim J-E, Ohe J-Y. A clinical retrospective study of implant as a risk factor for medication-related osteonecrosis of the jaw: surgery vs loading? Maxillofac Plast Reconstr Surg. 2023;45(1):31.","journal-title":"Maxillofac Plast Reconstr Surg"},{"issue":"8","key":"4138_CR14","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41415-024-7968-5","volume":"237","author":"R Arya","year":"2024","unstructured":"Arya R, Miles E, Sproat C, Patel D, Patel V. An institutional protocol including socket alveoplasty and primary closure following dental extractions for patients with an elevated risk of developing medication-related osteonecrosis of the jaw. Br Dent J. 2024;237(8):645\u201351.","journal-title":"Br Dent J"},{"key":"4138_CR15","doi-asserted-by":"crossref","unstructured":"Liu C, Xiong Y-T, Zhu T, Liu W, Tang W, Zeng W. Management of tooth extraction in patients taking antiresorptive drugs: an evidence mapping review and meta-analysis. J Clin Med. 2022;12(1).","DOI":"10.3390\/jcm12010239"},{"issue":"5","key":"4138_CR16","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","volume":"80","author":"SL Ruggiero","year":"2022","unstructured":"Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D. American association of oral and maxillofacial surgeons\u2019 position paper on Medication-Related osteonecrosis of the Jaws-2022 update. J Oral Maxillofac Surg. 2022;80(5):920\u201343.","journal-title":"J Oral Maxillofac Surg"},{"key":"4138_CR17","doi-asserted-by":"crossref","unstructured":"Jelin-Uhlig S, Weigel M, Ott B, Imirzalioglu C, Howaldt H-P, B\u00f6ttger S et al. Bisphosphonate-related osteonecrosis of the jaw and oral microbiome: clinical risk factors, pathophysiology and treatment options. Int J Mol Sci. 2024;25(15).","DOI":"10.3390\/ijms25158053"},{"issue":"11","key":"4138_CR18","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1007\/s00784-019-02828-w","volume":"23","author":"K McGowan","year":"2019","unstructured":"McGowan K, Ware RS, Acton C, Ivanovski S, Johnson NW. Both non-surgical dental treatment and extractions increase the risk of medication-related osteonecrosis of the jaw: case-control study. Clin Oral Investig. 2019;23(11):3967\u201375.","journal-title":"Clin Oral Investig"},{"issue":"4","key":"4138_CR19","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/odi.12708","volume":"24","author":"K McGowan","year":"2018","unstructured":"McGowan K, McGowan T, Ivanovski S. Risk factors for medication-related osteonecrosis of the jaws: A systematic review. Oral Dis. 2018;24(4):527\u201336.","journal-title":"Oral Dis"},{"issue":"4","key":"4138_CR20","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.tripleo.2006.06.004","volume":"102","author":"SL Ruggiero","year":"2006","unstructured":"Ruggiero SL, Fantasia J, Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102(4):433\u201341.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"5","key":"4138_CR21","doi-asserted-by":"publisher","first-page":"e752","DOI":"10.4317\/medoral.18076","volume":"18","author":"F Beninati","year":"2013","unstructured":"Beninati F, Pruneti R, Ficarra G. Bisphosphonate-related osteonecrosis of the jaws (Bronj). Med Oral Patol Oral Cir Bucal. 2013;18(5):e752\u20138.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"issue":"3","key":"4138_CR22","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1590\/1678-775720140506","volume":"23","author":"A Tardast","year":"2015","unstructured":"Tardast A, Sj\u00f6man R, L\u00f8es S, Abtahi J. Bisphosphonate associated osteomyelitis of the jaw in patients with bony exposure: prevention, a new way of thinking. J Appl Oral Sci. 2015;23(3):310\u20134.","journal-title":"J Appl Oral Sci"},{"issue":"2","key":"4138_CR23","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s10006-023-01204-z","volume":"28","author":"E Besi","year":"2024","unstructured":"Besi E, Pitros P. The role of leukocyte and platelet-rich fibrin in the prevention of medication-related osteonecrosis of the jaw, in patients requiring dental extractions: an observational study. Oral Maxillofac Surg. 2024;28(2):785\u201393.","journal-title":"Oral Maxillofac Surg"},{"issue":"3","key":"4138_CR24","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s10006-022-01094-7","volume":"27","author":"GK Parise","year":"2023","unstructured":"Parise GK, Costa BN, Nogueira ML, Sassi LM, Schussel JL. Efficacy of fibrin-rich platelets and leukocytes (L-PRF) in tissue repair in surgical oral procedures in patients using Zoledronic acid-case-control study. Oral Maxillofac Surg. 2023;27(3):507\u201312.","journal-title":"Oral Maxillofac Surg"},{"issue":"2","key":"4138_CR25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.cden.2013.12.006","volume":"58","author":"J Uyanne","year":"2014","unstructured":"Uyanne J, Calhoun CC, Le AD. Antiresorptive drug-related osteonecrosis of the jaw. Dent Clin North Am. 2014;58(2):369\u201384.","journal-title":"Dent Clin North Am"},{"issue":"5","key":"4138_CR26","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s11914-018-0474-4","volume":"16","author":"J Chang","year":"2018","unstructured":"Chang J, Hakam AE, McCauley LK. Current Understanding of the pathophysiology of osteonecrosis of the jaw. Curr Osteoporos Rep. 2018;16(5):584\u201395.","journal-title":"Curr Osteoporos Rep"},{"issue":"2","key":"4138_CR27","first-page":"925","volume":"29","author":"TL Ng","year":"2021","unstructured":"Ng TL, Tu MM, Ibrahim MFK, Basulaiman B, McGee SF, Srikanthan A, et al. Long-term impact of bone-modifying agents for the treatment of bone metastases: a systematic review. Support Care Cancer. 2021;29(2):925\u201343.","journal-title":"Support Care Cancer"},{"issue":"4","key":"4138_CR28","first-page":"e1","volume":"14","author":"R Seluki","year":"2023","unstructured":"Seluki R, Seluki M, Vaitkeviciene I, Jagelaviciene E. Comparison of the effectiveness of Conservative and surgical treatment of Medication-Related osteonecrosis of the jaw: a systematic review. J Oral Maxillofac Res. 2023;14(4):e1.","journal-title":"J Oral Maxillofac Res"},{"issue":"11","key":"4138_CR29","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1007\/s00198-016-3654-z","volume":"27","author":"J Zhou","year":"2016","unstructured":"Zhou J, Ma X, Wang T, Zhai S. Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses. Osteoporos Int. 2016;27(11):3289\u2013300.","journal-title":"Osteoporos Int"},{"key":"4138_CR30","doi-asserted-by":"crossref","unstructured":"Tang X, Zhang Q, Shi S, Yen Y, Li X, Zhang Y et al. Bisphosphonates suppress insulin-like growth factor 1-induced angiogenesis via the HIF-1alpha\/VEGF signaling pathways in human breast cancer cells. Int J Cancer. 2010;126(1).","DOI":"10.1002\/ijc.24710"},{"issue":"3","key":"4138_CR31","first-page":"220","volume":"51","author":"A Spanou","year":"2020","unstructured":"Spanou A, Nelson K, Ermer MA, Steybe D, Poxleitner P, Voss PJ. Primary wound closure and perioperative antibiotic therapy for prevention of bisphosphonate-related osteonecrosis of the jaw after tooth extraction. Quintessence Int. 2020;51(3):220\u20138.","journal-title":"Quintessence Int"},{"issue":"6","key":"4138_CR32","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jcms.2015.03.039","volume":"43","author":"S Otto","year":"2015","unstructured":"Otto S, Tr\u00f6ltzsch M, Jambrovic V, Panya S, Probst F, Ristow O, et al. Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development? J Craniomaxillofac Surg. 2015;43(6):847\u201354.","journal-title":"J Craniomaxillofac Surg"},{"issue":"1","key":"4138_CR33","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41368-020-00093-2","volume":"12","author":"L He","year":"2020","unstructured":"He L, Sun X, Liu Z, Qiu Y, Niu Y. Pathogenesis and multidisciplinary management of medication-related osteonecrosis of the jaw. Int J Oral Sci. 2020;12(1):30.","journal-title":"Int J Oral Sci"},{"key":"4138_CR34","doi-asserted-by":"crossref","unstructured":"Jacob G, Thomas, Aviv Ouanounou. Medication-related osteonecrosis of the jaw: a narrative review of risk factors, diagnosis, and management. Front Oral Maxillofacial Med. 2022;5.","DOI":"10.21037\/fomm-21-106"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04138-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-04138-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04138-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T14:33:24Z","timestamp":1765290804000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-04138-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4138"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-04138-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6664303\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were approved by the Ethical Committee of the School of Stomatology at the Fourth Military Medical University in Xi\u2019an, China.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted without any commercial or financial relationships that could potentially create a conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"619"}}